Treatment of Relapsing-Remitting Multiple Sclerosis After 24 Doses of Natalizumab: Evidence From an Italian Spontaneous, Prospective, and Observational Study (the TY-STOP Study).

Sabrina Realmuto, Giuseppe Salemi, Carolina Ionete, I-Jun Chou, Cris S. Constantinescu, Radu Tanasescu, Carolina Ionete

Research output: Contribution to journalArticlepeer-review

19 Citations (Scopus)
Original languageEnglish
Pages (from-to)954-960
Number of pages7
JournalJAMA Neurology
Volume71
Publication statusPublished - 2014

All Science Journal Classification (ASJC) codes

  • General Medicine

Cite this